This inventor holds 2 USPTO granted patents. Top assignee: Eromlife Co., Ltd.. Active years: 2005-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2007
Title: Mi Hyoun Park: Innovator in Microbial and Dietary Solutions
Introduction
Mi Hyoun Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of microbiology and dietary health. With a total of 2 patents, his work focuses on enhancing immune functions and promoting overall health through innovative solutions.
Latest Patents
One of Mi Hyoun Park's latest patents involves a novel genus microorganism, specifically EROM101 (KCCM-10517), which is derived from human intestines. This microorganism exhibits immune enhancement, anticancer, and antiviral activities. The invention highlights the potential applications of EROM101 in producing various products, including immune enhancement agents, anticancer agents, antimicrobial agents, food additives, and fermented products.
Another significant patent pertains to a diet composition that includes a variety of natural ingredients such as brown rice, job's tear, red beans, and various vegetables and herbs. This composition is designed to aid in reducing body weight and body fat, controlling body shape, and lowering serum cholesterol and neutral fat.
Career Highlights
Mi Hyoun Park is currently associated with Eromlife Co., Ltd., where he continues to develop innovative health solutions. His work is characterized by a commitment to improving human health through scientific research and practical applications.
Collaborations
He collaborates with notable colleagues, including Chang Won Choi and Sang Ho Hwang, who contribute to his research and development efforts.
Conclusion
Mi Hyoun Park's innovative work in microbiology and dietary solutions showcases his dedication to enhancing health and wellness. His patents reflect a deep understanding of the interplay between microorganisms and human health, paving the way for future advancements in these fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile